Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Ataeinia, P."'
Autor:
Ataeinia, Bahar, Heidari, Pedram
Novel diagnostic and therapeutic radiopharmaceuticals are increasingly becoming a central part of personalized medicine. Continued innovation in the development of new radiopharmaceuticals is key to sustained growth and advancement of precision medic
Externí odkaz:
http://arxiv.org/abs/2108.02354
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mozhdeh Sojoodi, Derek J. Erstad, Stephen C. Barrett, Shadi Salloum, Shijia Zhu, Tongqi Qian, Selene Colon, Eric M. Gale, Veronica Clavijo Jordan, Yongtao Wang, Shen Li, Bahar Ataeinia, Sasan Jalilifiroozinezhad, Michael Lanuti, Lawrence Zukerberg, Peter Caravan, Yujin Hoshida, Raymond T. Chung, Gautam Bhave, Georg M. Lauer, Bryan C. Fuchs, Kenneth K. Tanabe
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 13, Iss 5, Pp 1483-1509 (2022)
Background & Aims: During liver fibrosis, tissue repair mechanisms replace necrotic tissue with highly stabilized extracellular matrix proteins. Extracellular matrix stabilization influences the speed of tissue recovery. Here, we studied the expressi
Externí odkaz:
https://doaj.org/article/6ba526f7c87641729036d4c0c5724ed3
Autor:
Reyhaneh Manafi-Farid, Bahar Ataeinia, Shaghayegh Ranjbar, Zahra Jamshidi Araghi, Mohammad Mobin Moradi, Christian Pirich, Mohsen Beheshti
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Immuno-positron emission tomography (immunoPET) is a molecular imaging modality combining the high sensitivity of PET with the specific targeting ability of monoclonal antibodies. Various radioimmunotracers have been successfully developed to target
Externí odkaz:
https://doaj.org/article/26bf6c0a5e174ea7829bf92113453a6e
Autor:
SeyedAhmad SeyedAlinaghi, Behnam Farhoudi, Bahar Ataeinia, Omid Dadras, Mostafa Hosseini, Sirous Jafari, Elham Mazaheri-Tehrani, Ramin Alasvand, Mohammad Shahbazi, Minoo Mohraz
Publikováno v:
Journal of Health Research, Vol 34, Iss 6, Pp 463-473 (2020)
Purpose – The aim of this study was to compare the defined indicators of tuberculosis (TB) control program in the intervention and control prisons, after implementation of the national clinical protocol for TB and HIV management in Iranian prisons,
Externí odkaz:
https://doaj.org/article/abfdf60c908c4753bdb6495b2df3bdf2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bahar Ataeinia, Sahar Saeedi Moghaddam, Mahsima Shabani, Kimiya Gohari, Ali Sheidaei, Nazila Rezaei, Shohreh Naderimagham, Erfan Ghasemi, Mahtab Rouhifard Khalilabad, Shahin Roshani, Yosef Farzi, Farshad Farzadfar
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Breast cancer is the most common cancer among women, causing considerable burden and mortality. Demographic and lifestyle transitions in low and low-middle income countries have given rise to its increased incidence. The successful management of canc
Externí odkaz:
https://doaj.org/article/c87c3cf3ee844fa7b48ffc2da671f9d3
Autor:
Carolina de Aguiar Ferreira, Pedram Heidari, Bahar Ataeinia, Nicoleta Sinevici, Alyssa Granito, Hritik Mahajan Kumar, Eric Wehrenberg-Klee, Umar Mahmood
Publikováno v:
Pharmaceutics, Vol 14, Iss 7, p 1460 (2022)
Although immune checkpoint inhibitors (ICI) have revolutionized cancer management, patient response can be heterogeneous, and the development of ICI resistance is increasingly reported. Novel treatment strategies are necessary not only to expand the
Externí odkaz:
https://doaj.org/article/32c52d25bf914713bd2d3d544cafb437
Autor:
Nicoleta Sinevici, Bahar Ataeinia, Veronica Zehnder, Kevin Lin, Lauren Grove, Pedram Heidari, Umar Mahmood
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Triple Negative Breast Cancer (TNBC) is an aggressive form of Breast Cancer (BC). Numerous kinase inhibitors (KI) targeting different pathway nodes have shown limited benefit in the clinical setting. In this study, we aim to characterize the extent o
Externí odkaz:
https://doaj.org/article/28ff39c286a44025976bf050a3465576